Annual EBITDA
-$9.30 M
-$2.42 M-35.17%
December 31, 2023
Summary
- As of February 7, 2025, THAR annual EBITDA is -$9.30 million, with the most recent change of -$2.42 million (-35.17%) on December 31, 2023.
- During the last 3 years, THAR annual EBITDA has fallen by -$7.13 million (-328.53%).
- THAR annual EBITDA is now -576.36% below its all-time high of -$1.38 million, reached on December 1, 2021.
Performance
THAR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.79 M
-$1.47 M-63.50%
September 30, 2024
Summary
- As of February 7, 2025, THAR quarterly EBITDA is -$3.79 million, with the most recent change of -$1.47 million (-63.50%) on September 30, 2024.
- Over the past year, THAR quarterly EBITDA has dropped by -$1.54 million (-68.46%).
- THAR quarterly EBITDA is now -239.89% below its all-time high of $2.71 million, reached on December 1, 2021.
Performance
THAR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$10.84 M
-$1.98 M-22.30%
September 30, 2024
Summary
- As of February 7, 2025, THAR TTM EBITDA is -$10.84 million, with the most recent change of -$1.98 million (-22.30%) on September 30, 2024.
- Over the past year, THAR TTM EBITDA has dropped by -$1.97 million (-22.16%).
- THAR TTM EBITDA is now -2972.70% below its all-time high of -$352.70 thousand, reached on September 1, 2020.
Performance
THAR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
THAR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.2% | -68.5% | -22.2% |
| 3 y3 years | -328.5% | -62.8% | -21.7% |
| 5 y5 years | -541.4% | -62.8% | -21.7% |
THAR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -576.4% | at low | -239.9% | at low | -1634.8% | at low |
| 5 y | 5-year | -576.4% | at low | -239.9% | at low | -2972.7% | at low |
| alltime | all time | -576.4% | at low | -239.9% | at low | -2972.7% | at low |
Tharimmune EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.79 M(+63.5%) | -$10.84 M(+22.3%) |
| Jun 2024 | - | -$2.32 M(+3.0%) | -$8.86 M(-0.1%) |
| Mar 2024 | - | -$2.25 M(-9.0%) | -$8.87 M(-4.6%) |
| Dec 2023 | -$9.30 M(+35.2%) | -$2.47 M(+36.2%) | -$9.30 M(+8.2%) |
| Sep 2023 | - | -$1.82 M(-22.0%) | -$8.60 M(-3.5%) |
| Jun 2023 | - | -$2.33 M(-13.1%) | -$8.91 M(+8.4%) |
| Mar 2023 | - | -$2.68 M(+51.8%) | -$8.21 M(+19.3%) |
| Dec 2022 | -$6.88 M | - | - |
| Dec 2022 | - | -$1.77 M(-17.0%) | -$6.88 M(+186.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$2.13 M(+30.0%) | -$2.40 M(+168.8%) |
| Jun 2022 | - | -$1.64 M(+21.1%) | -$894.40 K(+43.2%) |
| Mar 2022 | - | -$1.35 M(-149.8%) | -$624.70 K(-54.6%) |
| Dec 2021 | -$1.38 M(-36.6%) | $2.71 M(-539.0%) | -$1.38 M(-73.9%) |
| Sep 2021 | - | -$617.60 K(-54.8%) | -$5.28 M(+5.3%) |
| Jun 2021 | - | -$1.37 M(-35.0%) | -$5.01 M(+37.5%) |
| Mar 2021 | - | -$2.10 M(+76.7%) | -$3.64 M(+136.3%) |
| Dec 2020 | -$2.17 M(+49.7%) | -$1.19 M(+237.3%) | -$1.54 M(+337.3%) |
| Sep 2020 | - | -$352.70 K | -$352.70 K |
| Dec 2019 | -$1.45 M | - | - |
FAQ
- What is Tharimmune annual EBITDA?
- What is the all time high annual EBITDA for Tharimmune?
- What is Tharimmune annual EBITDA year-on-year change?
- What is Tharimmune quarterly EBITDA?
- What is the all time high quarterly EBITDA for Tharimmune?
- What is Tharimmune quarterly EBITDA year-on-year change?
- What is Tharimmune TTM EBITDA?
- What is the all time high TTM EBITDA for Tharimmune?
- What is Tharimmune TTM EBITDA year-on-year change?
What is Tharimmune annual EBITDA?
The current annual EBITDA of THAR is -$9.30 M
What is the all time high annual EBITDA for Tharimmune?
Tharimmune all-time high annual EBITDA is -$1.38 M
What is Tharimmune annual EBITDA year-on-year change?
Over the past year, THAR annual EBITDA has changed by -$2.42 M (-35.17%)
What is Tharimmune quarterly EBITDA?
The current quarterly EBITDA of THAR is -$3.79 M
What is the all time high quarterly EBITDA for Tharimmune?
Tharimmune all-time high quarterly EBITDA is $2.71 M
What is Tharimmune quarterly EBITDA year-on-year change?
Over the past year, THAR quarterly EBITDA has changed by -$1.54 M (-68.46%)
What is Tharimmune TTM EBITDA?
The current TTM EBITDA of THAR is -$10.84 M
What is the all time high TTM EBITDA for Tharimmune?
Tharimmune all-time high TTM EBITDA is -$352.70 K
What is Tharimmune TTM EBITDA year-on-year change?
Over the past year, THAR TTM EBITDA has changed by -$1.97 M (-22.16%)